Koninklijke Philips NV vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Koninklijke Philips NV trades at $24.94 (market cap $24.61B), while Vanguard Intermediate Term Corporate Bond ETF trades at $80.48. The key difference: Koninklijke Philips NV pays a 4.05% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| PHG | VCIT | |
|---|---|---|
Market Cap | $24.61B | — |
Sector | Health | Fixed Income |
52-Week High | $32.91 | $84.82 |
52-Week Low | $25.02 | $80.31 |
Enterprise Value | $31.21B | — |
Dividend Yield | 4.05% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $25.29, down 2.32% today, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with Q2 2026 EPS of $0.57 beating expectations of $0.40, and positive net income of $895M in 2025 reversing previous losses. Recent product launches in women's health and AI-powered medical devices demonstrate innovation momentum.
The outlook is mixed with strong fundamentals and analyst support (36% buy ratings) offset by technical weakness. Key opportunities include margin expansion and new product adoption, while risks involve cybersecurity threats and competitive pressures in healthcare technology.
VCIT trades at $80.46, down 0.09% on the day, with technical indicators showing a bearish trend from moving averages but bullish momentum from oscillators like the RSI. Recent news highlights institutional buying and favorable comparisons to peers due to its low 0.03% expense ratio and 4.8% yield, positioning it as a cost-effective intermediate-term corporate bond ETF.
The outlook for VCIT is supported by strong income appeal and institutional interest, but risks include interest rate sensitivity and market volatility. Analysts view it positively for its yield and low costs, though the bearish technical trend warrants caution for near-term price movements.
Trailing returns across standard periods
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →